BASAGLAR KwikPen
NDC 0002-7715, Insulin glargine, injection, solution, from Eli Lilly and Company.
- Product NDC
- 0002-7715
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA205692
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-7715-59 | 00002771559 | 5 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0ad21db3-2b1c-4ed9-a687-bdd6a74d0aaeNADAC price for package 00002771559
GET /v1/drugs/nadac/00002771559
Use it
Look up 0002-7715 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-7715. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.